Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (29)

2023

  1. Diagnosis, evaluation and monitoring of acute hepatic porphyria

    Medicina Clinica

  2. Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2021

  1. Acute intermittent porphyria, givosiran, and homocysteine

    Journal of Inherited Metabolic Disease

2017

  1. Prognostic models for locally advanced cervical cancer: External validation of the published models

    Journal of Gynecologic Oncology, Vol. 28, Núm. 5

2015

  1. Vitamin D-binding protein as a biomarker of active disease in acute intermittent porphyria

    Journal of Proteomics, Vol. 127, pp. 377-385

2014

  1. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro

    American Journal of Hematology, Vol. 89, Núm. 7, pp. 689-694

2013

  1. Familial porphyria cutanea tarda in Spain: Characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation

    Gene, Vol. 522, Núm. 1, pp. 89-95

2012

  1. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis

    Gene, Vol. 508, Núm. 1, pp. 15-20

2011

  1. Tumour VEGF/Non Tumour VEGF protein expression ratio as a biomarker for survival in colorectal cancer patients

    European Journal of Surgical Oncology, Vol. 37, Núm. 6, pp. 526-531

  2. Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man

    European Journal of Haematology, Vol. 86, Núm. 3, pp. 260-264

2010

  1. Hepcidin treatment in Hfe-/- mice diminishes plasma iron without affecting erythropoiesis

    European Journal of Clinical Investigation, Vol. 40, Núm. 6, pp. 511-517

2009

  1. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: Potential novel players in the progression of liver injury

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 29-37

  2. Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria

    Cellular and Molecular Biology, Vol. 55, Núm. 2, pp. 55-63

  3. In vivo effect an luteinizing hormone-releasing hormone analog on vascular endothelial growth factor and epidermal growth factor receptor expression in mammary tumors

    Journal of Carcinogenesis, Vol. 8

  4. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 38-44

  5. Mutation in CNR1 gene and VEGF expression in esophageal cancer

    Tumori, Vol. 95, Núm. 1, pp. 68-75

  6. Single nucleotide change in the cannabinoid receptor-1 (CNR1) gene in colorectal cancer outcome

    Oncology, Vol. 76, Núm. 6, pp. 435-441

2003

  1. Colorectal cancer relapse: Allelic alterations associated with tumour marker overexpression

    Oncology, Vol. 65, Núm. 2, pp. 146-151

2000

  1. Lipoprotein abnormalities in patients with asymptomatic acute porphyria

    Clinica Chimica Acta, Vol. 294, Núm. 1-2, pp. 37-43

  2. Serum levels of coenzyme Q10 in patients with Alzheimer's disease

    Journal of Neural Transmission, Vol. 107, Núm. 2, pp. 233-239